Market Research Future is Leading Research Company which has provide a Half Cooked report on “Global Genetic Engineering Market Research Report–Forecast till 2027” for Better Understanding of Revenue Model and Sources of Revenue
Top Key Players:
Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), and Horizon Discovery Group Plc. (U.K.). The other players of the market are Transposagen Biopharmaceuticals Inc. (U.S.)., New England Biolabs (U.S), Genscript Biotech Corporation (U.S.), Lonza Group Ltd. (Switzerland), Inc. (U.S.), Origene Technologies, Inc. (U.S.), and Integrated DNA Technologies, Inc (U.S.)
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1528
Global Genetic Engineering Market – Overview:
The use of various technology to manipulate genome of an organism or change its genetic makeup of an organism is called genetic engineering. Gene is a basic structural and unit of functional unit of heredity. It’s due to genes that we have any particular trait. DNA recombinant technology is common genetic engineering method used. It involves artificial addition of a foreign gene to organism genome thus altering its genetic makeup. Genetic engineering is generally done to eliminate any hereditary problem or to provide additional advantage to an organism, or cure to any disease like cancer. For instance, Roundup ready corn by Monsanto is an example of use of genetic engineering in agriculture.
The factors boosting up the market growth are; increase technologies for gene, use of gene therapy for cancer treatment, CRISPR technology for genome editing, rise in use of advanced technologies and research in genetic engineering field. For instance insulin was previously produced from pig and goat but now genetically engineered E.coli are used for production of insulin. Thus prevalence of diabetes is also a contributing factor in market growth.
Government laws, lack of awareness in middle income countries, high cost involved are the market restraint factors.
Global genetic engineering market is expected to reach USD 6.90 billion by 2023 at a CAGR of 12.48% during period 2017 to 2023.
The market is forecasted to demonstrate a double digit growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period 2017 – 2027.
Global Genetic Engineering Market – competitive Analysis:
Thermo Fisher Scientific Inc is a global leader among scientific industries. Through their premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services they aim to offer an unmatched combination of innovative technologies, solve complex analytical challenges and accelerate life sciences & medical research. It has contributed significantly in genetic engineering by offering solutions for genome editing, cloning DNA assembly, as well as Agrobacterium tumefaciens LBA4404 for plant-cell transformation, RT-PCR, Affymetrix microarray analysis products and Comprehensive sequencing solutions. In year 2015 Thermo fisher launched online GeneArt CRISPR Search and Design Tool. The design tool suggests the top 6 sequence designs and gives a list of potential off-target effects for each as well as 600,000 predesigned CRISPR gRNAs for targeting human and mouse genes. Thus it made Genome editing simpler for the user, making it a popular tool in the field of genetic engineering research. Other recent products in genetic engineering market are Ion S5 sequencing systems, Sanger sequencing, QuantiGene Plex Assay, QuantiGene Singleplex Assay, QuantStudio family and QuantiGene Singleplex HT Assay.
New England Biolabs headquartered in the U.S is a leader in the discovery and development of molecular biology reagents, restriction enzymes and commercialization of recombinant and native enzymes for genomic research. NEB presented NEBNext technologies, which is its latest innovation in NGS sample preparation including enzymatic DNA fragmentation, target enrichment, single-cell RNA sequencing, and methylation analysis. NEB is looking past the enzymes and has launched several products involving CRISPR technology too.
Browse Full Reports @ https://www.marketresearchfuture.com/reports/genetic-engineering-market-1528
Global Genetic Engineering Market – Regional Analysis:
Home to some of the world’s largest pharmaceutical &biotechnology companies, research giants North America stands as an undisputed leader for genome engineering market. The region has witnessed a significant rise in research and development activities in the field of genetics and its applications across these industries
North America is anticipated to lead the Global Genetic Engineering Market owing to the high prevalence of diabetes, cancer, neurological disorders,., increasing acceptance of new technologies, the presence of a large customer base in this region is likely to propel the growth of the syringe and needle market in North America.
Europe stands second in the Global Genetic Engineering Market. The European market is expected to grow during the forecast period due to various government legislative reforms providing regulatory guidelines to manufacturing companies, the growing research and developments sector, need for advanced treatments along with growing need for better healthcare infrastructure.
Asia Pacific is the fastest region in the Global Genetic Engineering Market. Country’s like India, Japan, Korea China and Singapore of Asia Pacific region are adapting to newer technologies and are the hub of life sciences and medical science research. Considering the fact that presence of huge population suffering from diabetes, cancer, and cardiovascular disease, these countries are quickly adapting to new technologies so as to improve the health of every citizen. Government is also supporting the same by investing in research and development in clinical research sector as well as in building proper healthcare infrastructure. Additionally, lots of global giants in Pharma &biotech industries are setting up their research lab in these emerging nation, will also give a boost up to Asia Pacific market.
The Middle East & Africa holds the least share in the market owing to the presence of low-income countries and low healthcare expenditure, especially within the African region. Within this region, the Middle East leads the market due to the presence of developed economies like United Arab Emirates, Saudi Arabia who have good research infrastructure as well as skilled Professionals.
Ask Question to Professional @ https://www.marketresearchfuture.com/enquiry/1528
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312